Procalcitonin in Respiratory Disease: Use as a Biomarker for Diagnosis and Guiding Antibiotic Therapy

Breathe - United Kingdom
doi 10.1183/20734735.0258-2019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Procalcitonin (PCT) - The New Era for Diagnosis of Infection and Guiding Antibiotic Decisions

KYAMC Journal
2017English

Use of Procalcitonin as a Biomarker for Sepsis in Moderate to Major Paediatric Burns

Trauma
SurgeryCritical CareEmergency MedicineIntensive Care Medicine
2018English

Low Procalcitonin, Community Acquired Pneumonia, and Antibiotic Therapy

The Lancet Infectious Diseases
Infectious Diseases
2018English

Procalcitonin Testingreduce Unnecessary Antibiotic Use in Bacterial Infection

Asian Pacific Journal of Environment and Cancer
2019English

The Making of a CYP3A Biomarker Panel for Guiding Drug Therapy

Journal of Personalized Medicine
Medicine
2012English

Early Procalcitonin Kinetics and Adequate Empiric Antibiotic Therapy in Critically Ill

English

Procalcitonin-Guided Antibiotic Therapy for Septic Patients in the Surgical Intensive Care Unit

Journal of Intensive Care
Critical CareIntensive Care Medicine
2015English

Correction To: Procalcitonin-Guided Antibiotic Therapy in Critically Ill Adults: A Meta-Analysis

BMC Infectious Diseases
Infectious Diseases
2019English

Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer's Disease

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy